Trial intelligence / Profile preview

Rectal Misoprostol for Intraoperative Blood Loss in Myomectomy

NCT02908295Phase 4Completed

Sponsor
Ministry of Public Health
Start
Sep 2016
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in uterine leiomyoma comparing Rectal Misoprostol with Placebo (2 arms). Primary endpoint: Mean intraoperative blood loss. Started Sep 2016; status: completed.

02

Drugs

misoprostol
03

Conditions

uterine leiomyoma

Beyond the preview

Go deeper on NCT02908295.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02908295.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call